Neurol. praxi. 2026;27(4):263-267 | DOI: 10.36290/neu.2026.039

Myoclonus - basic orientation for clinical practice

MUDr. Ján Necpál, PhD.1, 2, MUDr. Orest Shabatiuk1, 2
1 Neurologické oddelenie, Nemocnica Zvolen, a. s., Zvolen
2 Centrum pre liečbu parkinsonizmu a extrapyramídových porúch, Nemocnica Zvolen, a. s., Zvolen

Myoclonus, belonging to the group of hyperkinetic movement disorders, is manifested by short and rapid muscle jerks, caused by their active contraction, or by a sudden loss of muscle activity. Myoclonus is caused by a number of different causes, which may have different anatomical correlates. However, a detailed history, clinical examination, neuroimaging methods and knowledge of neurophysiological testing can often narrow the diagnostic perimeter to a specific disease and thus significantly accelerate the diagnostic process. Within this framework, it is always necessary to first think about the exclusion of potentially reversible causes.

Keywords: myoclonus, classification of myoclonus, clinical examination, diagnostic approach.

Received: May 27, 2026; Revised: July 16, 2026; Accepted: July 20, 2026; Prepublished online: July 20, 2026; Published: October 2, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Necpál J, Shabatiuk O. Myoclonus - basic orientation for clinical practice. Neurol. praxi. 2026;27(4):263-267. doi: 10.36290/neu.2026.039.
Download citation

References

  1. Albanese A, Bhatia KP, Fung VSC, et al. Definition and Classification of Dystonia. Mov Disord. 2025;40:1248-1259. Go to original source... Go to PubMed...
  2. Adams RD, Foley JM. The neurological disorder associated with liver disease. Res Publ Assoc Res Nerv Ment Dis. 1953;32:198-237.
  3. Bhatia KP, Bain P, Bajaj N, et al. Consensus Statement on the classification of tremors. From the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018;33:75-87. Go to original source... Go to PubMed...
  4. Burton MA, Dalrymple WA, Figar R. Assessment and Treatment of Myoclonus: A Review. touchREVIEWS in Neurology. 2022;18:38-41. Go to original source...
  5. Chandarana M, Saraf U, Divya KP, et al. Myoclonus - A Review. Ann Indian Acad Neurol. 2021;24:327-338. Go to original source...
  6. Donaldson I, Marsden CD, Schneider S, et al. Marsden's book of movement disorders. Oxford University Press. 2012. Go to original source...
  7. Edwards MJ, Stamelou M, Quinn N, et al. Parkinson's disease and other movement disorders, 2nd Edition, Oxford University Press. 2016. Go to original source...
  8. Fahn S, Jankovic J. Principles and Practice of Movement Disorders (1st ed.). Churchill Livingstone Elsevier. 2007. Go to original source...
  9. Friedreich N. Neuropathologische Beobachtung beim paramyoklonus multiplex. Virchows Archiv fur Pathologische Anatomie und Physiologie und fur Klinische Medizin. 1881;86:421-434. Go to original source...
  10. Kojovic M, Cordivari C, Bhatia K. Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord. 2011;4:47-62. Go to original source... Go to PubMed...
  11. aLatorre A, Ganos C, Hamada M, et al. Diagnostic Utility of Clinical Neurophysiology in Jerky Movement Disorders: A Review from the MDS Clinical Neurophysiology Study Group. Mov Disord Clin Pract. 2025;12:272-284. Go to original source... Go to PubMed...
  12. bLatorre A, van der Veen S, Pena A, et al. IAPRD new consensus classification of myoclonus. Parkinsonism Relat Disord. 2025;132:107216. Go to original source... Go to PubMed...
  13. Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus, In: Marsden CD, Fahn C (Eds.). Movement Disorders, Butterworth Scientific, London. 1982; pp. 196-248. Go to original source...
  14. Peña AB. Myoclonus, In: Wolters EC, Baumann CR. International Compendium of Movement Disorders (Eds.), Cambridge University Press. 2025; 523-539. Go to original source...
  15. Riva A, D'Onofrio G, Ferlazzo E, et al. Myoclonus: Differential diagnosis and current management. Epilepsia Open. 2024;9:486-500. Go to original source... Go to PubMed...
  16. Sanders AE, Zafar N, Sharma S. Myoclonus. 2024 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan.
  17. Seegmüller A. Ein Fall von von Paramyoklonus multiplex (Friedreich) (Myoclonia congenita). Deutsche Medizinische Wochenschift. 1886;12:405-412. Go to original source...
  18. Striano P, Nobile C. The genetic basis of juvenile myoclonic epilepsy. Lancet Neurol. 2018;17:493-495. Go to original source... Go to PubMed...
  19. van Gerpen JA. A retrospective study of the clinical and electrophysiological characteristics of 32 patients with orthostatic myoclonus. Parkinsonism Relat Disord. 2014;20:889-93. Go to original source...
  20. van der Veen S, Zutt R, Klein C, et al. Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force. Mov Disord. 2019;34:1602-1613. Go to original source... Go to PubMed...
  21. Verma R, Holla VV, Pandey S, et al. Multifocal myoclonus as a heralding manifestation of Wilson disease. J Pediatr Neurosci. 2016;11:358-360. Go to original source... Go to PubMed...
  22. Zutt R, van Egmond ME, Elting JW, et al. A novel diagnostic approach to patients with myoclonus. Nat Rev Neurol. 2015;11:687-97. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.